Perlara Overview

  • Year Founded
  • 2014

Year Founded

  • Status
  • Private

  • Employees
  • 5

Employees

  • Latest Deal Type
  • 2ndary - Private

  • Investors
  • 7

Perlara General Information

Description

Developer of a drug discovery platform designed to cure rare diseases and learn how genes work across diseases. The company's platform creates disease models using animals that share genetic similarities with humans, and that offer to screen massive numbers of disease models and drug candidates properly and at low cost, enabling researchers to have assistance in the field of drug discovery.

Contact Information

Website
www.perlara.com
Formerly Known As
Perlstein Lab
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • 6000 Shoreline Court
  • Suite 204
  • San Francisco, CA 94080
  • United States
+1 (617)
Primary Industry
Drug Discovery
Other Industries
Biotechnology
Vertical(s)
HealthTech, Life Sciences
Corporate Office
  • 6000 Shoreline Court
  • Suite 204
  • San Francisco, CA 94080
  • United States
+1 (617)

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Perlara Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
6. Secondary Transaction - Private Completed Clinical Trials - Phase 3
5. Accelerator/Incubator 01-May-2019 Completed Clinical Trials - Phase 3
4. Early Stage VC (Series B) 01-Nov-2017 Completed Clinical Trials - Phase 3
3. Accelerator/Incubator 23-Mar-2016 Completed Startup
2. Accelerator/Incubator $2.5M Completed Startup
1. Early Stage VC (Series A) 01-Apr-2015 $2.5M $2.5M Completed Startup
To view Perlara’s complete valuation and funding history, request access »

Perlara Cap Table

Stock # of Shares
Authorized		 Par Value Dividend Rate (%) Original
Issue Price		 Liquidation Liquidation
Pref. Multiple		 Conversion Price % Owned
Series B2
Series B1
Series B 9,145,647 $0.000010 8% $0.67 $0.67 1x $0.67 28.86%
Series A 4,500,000 $0.000010 8% $0.5 $0.5 1x $0.5 14.29%
To view Perlara’s complete cap table history, request access »

Perlara Patents

  • 9

    Total Documents Applications and Grants

  • Total Patents Families

  • 3

    Granted

  • 1

    Pending

  • Expiring in next 12 mo

Perlara Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
WO-2026073262-A1 Methods for treating dhdds-related disorders Pending 30-Sep-2024
US-11160794-B2 Methods for treating congenital disorders of glycosylation Active 20-Aug-2018
US-20210030721-A1 Methods for treating congenital disorders of glycosylation Active 20-Aug-2018
WO-2020040831-A1 Methods for treating congenital disorders of glycosylation Inactive 20-Aug-2018
CA-3018784-A1 Fused heterocyclic organic compounds and uses thereof Inactive 21-Mar-2016 A61K31/53
To view Perlara’s complete patent history, request access »

Perlara Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Perlara Investors (7)

Investor Name Investor Type Holding Investor Since Participating Rounds
MBC BioLabs Accelerator/Incubator
Pivotal Alpha Corporation Minority
Safe (Specialty Retail) Corporation Minority
Y Combinator Accelerator/Incubator Minority
Alpha (Investor) Corporation Minority
You’re viewing 5 of 7 investors. Get the full list »

Perlara Investments (2)

Perlara’s most recent deal was a Seed Round with Keylika for . The deal was made on 30-Nov-2022.

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
Keylika 30-Nov-2022 Seed Round Drug Discovery
Maggie's Pearl 01-Aug-2020 Joint Venture Drug Discovery
To view Perlara’s complete investments history, request access »

Ready to get started?

Request a free trial

Perlara FAQs

  • When was Perlara founded?

    Perlara was founded in 2014.

  • Where is Perlara headquartered?

    Perlara is headquartered in San Francisco, CA.

  • What is the size of Perlara?

    Perlara has 5 total employees.

  • What industry is Perlara in?

    Perlara’s primary industry is Drug Discovery.

  • Is Perlara a private or public company?

    Perlara is a Private company.

  • What is Perlara’s current revenue?

    The current revenue for Perlara is .

  • How much funding has Perlara raised over time?

    Perlara has raised $10M.

  • Who are Perlara’s investors?

    MBC BioLabs, Pivotal Alpha, Safe (Specialty Retail), Y Combinator, and Alpha (Investor) are 5 of 7 investors who have invested in Perlara.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more

  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process